Tropic Biosciences is focused on enhancing tropical agriculture through advanced genetic innovation, particularly targeting staple crops such as bananas, coffee, and rice. Their mission is to improve the productivity and sustainability of these crops, making them more resilient to climate change, tastier, and less dependent on pesticides. By addressing the challenges posed by a growing global population, Tropic aims to support farmers and ensure food security while benefiting both consumers and the environment.

Central to Tropic's approach is their proprietary gene editing platform, GEiGS®, which integrates CRISPR gene editing with RNA interference (RNAi) technology. This combination allows for precise modifications to crop genetics, enhancing resistance to diseases and minimizing waste throughout the supply chain. By leveraging these cutting-edge technologies, Tropic Biosciences is pioneering new possibilities in crop improvement, ultimately striving to create a paradigm shift in agricultural practices that prioritizes both productivity and sustainability.

United Kingdom

Tropic Biosciences develops high-performing commercial varieties of tropical crops whichpromote grower well being, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. Some of the products being developed are disease resistant bananas and caffiene-free coffee.

Tropic Biosciences

Company Details